Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against CVRx, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is CVRx, Inc. (CVRX) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). Investors who purchased CVRx securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether CVRx has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On August 6, 2026, CVRx reported second-quarter earnings, including that “In May of 2026, [the Company] received a civil investigative demand from the U.S. Department of Justice related to certain sales and marketing practices.” The Company disclosed the Department of Justice demand “requested information and documents regarding an investigation into whether we caused the submission of false claims to government health insurance programs by improperly marketing our device, offering or paying kickbacks to healthcare providers or providing false information to government health insurance programs.” CVRx further lowered its full-year revenue guidance to $58 million–$60 million from $63 million–$67 million, and stated, among other things, the “rapid pace of hiring has strained our onboarding and training processes” and “the scale of the turnover, the slower pace of the territory manager productivity ramp, and the concentration of these new hires in a subset of our regions” necessitated the guidance reset. Following this news, CVRx’s stock price dropped.
What Should CVRx, Inc. (CVRX) Investors Do?
If you are aware of any facts relating to this investigation or purchased CVRx securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Did CVRx, Inc. (CVRX) Stock React?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”